EMEA-002546-PIP01-19

Table of contents

Key facts

Active substance
Tominersen
Therapeutic area
Neurology
Decision number
P/0264/2020
PIP number
EMEA-002546-PIP01-19
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of Huntington's disease
Route(s) of administration
Intrathecal use
Contact for public enquiries
Roche Registration GmbH

Tel. +41 6168 79411
E-mail: global.paediatrics@roche.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating